New Tests (10)
FISH
BCL6/MYC t(3;8) Alternative Name BCL6/MYC Translocation Methodology FISH Test Description Probes: BCL6/MYC t(3;8) Disease(s): B-cell lymphoma, double-hit lymphoma,…
In Situ Hybridization (ISH)
CMV ISH Alternative Name Cytomegalovirus by ISH Methodology In Situ Hybridization (ISH) Test Description In situ hybridization for detection of cytomegalovirus (CMV)…
Immunohistochemistry (IHC)
FOLR1 FDA (ELAHERE™) for Ovarian Carcinoma Alternative Name FOLR1 IHC CDx, Folate Receptor alpha (FRα), FOLR1 (FOLR1-2.1) RxDx Assay Methodology Immunohistochemistry (IHC) Test…
Molecular
Microsatellite Instability (MSI) by PCR Alternative Name Microsatellite Instability Analysis Methodology Molecular Test Description PCR and fragment analysis of paired…
Molecular
Neo Comprehensive - Solid Tumor Methodology Molecular Test Description Neo Comprehensive™ - Solid Tumor is a broad, next-generation sequencing panel for pan-solid tumor indications. The assay detects…
Molecular
Neo Comprehensive™ - Myeloid Disorders Alternative Name Comprehensive Myeloid Disorders, Myeloid CGP, Comprehensive Myeloid Methodology Molecular Test Description The…
Molecular
NeoTYPE® DNA & RNA - Brain Alternative Name Brain Tumor Profile Methodology Molecular Test Description NeoTYPE® DNA & RNA - Brain uses targeted next-generation…
Molecular
NeoTYPE® DNA & RNA - Lung Methodology Molecular Test Description NeoTYPE® DNA & RNA - Lung is a targeted next-generation sequencing profile that detects single nucleotide variants (SNV),…
Immunohistochemistry (IHC)
PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC Alternative Name PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/Esophageal Adenocarcinoma Methodology Immunohistochemistry (IHC) Test Description…
Molecular
RaDaR® Methodology Molecular Test Description RaDaR is a tumor-informed liquid biopsy test for the detection of minimal or molecular residual disease (MRD). RaDaR can be utilized for patients with…
Immunohistochemistry (IHC)
CD30 Methodology Immunohistochemistry (IHC) Test Description CD30 is a lymphocyte activation antigen, related to tumor necrosis factor. It is expressed in activated B-, T- and NK cells. Positive…
Immunohistochemistry (IHC)
CD31 Methodology Immunohistochemistry (IHC) Test Description CD31 is a 130kDa transmembrane glycoprotein that is shared by vascular lining cells, megakaryocytes and platelets. This marker is highly…
Immunohistochemistry (IHC)
CD33 Methodology Immunohistochemistry (IHC) Test Description CD33 is a useful marker to identify cells of myeloid and monocytic lineage, leukemias and myeloproliferative neoplasms derived from these…
Immunohistochemistry (IHC)
CD34 Methodology Immunohistochemistry (IHC) Test Description CD34, a single chain transmembrane glycoprotein, is selectively expressed on human lymphoid and myeloid hematopoietic progenitor cells and…
Immunohistochemistry (IHC)
CD35 Methodology Immunohistochemistry (IHC) Test Description CD35 antigen is a transmembrane protein of 160-250 kDa that binds complement components C3b and C4b. It mediates phagocytosis by…
Immunohistochemistry (IHC)
CD38 Methodology Immunohistochemistry (IHC) Test Description CD38 is a transmembrane protein that is highly expressed on thymocytes. It is also present on activated T-cells and terminally…
Immunohistochemistry (IHC)
CD4 Methodology Immunohistochemistry (IHC) Test Description CD4, a single chain transmembrane glycoprotein, is found on a T-cell subset (helper/inducer). It is also present on a variety of monocyte-…
Immunohistochemistry (IHC)
CD42b Methodology Immunohistochemistry (IHC) Test Description CD42b stains normal platelets, megakaryocytes, and megakaryoblasts. In diseased cells, blasts in transient myeloproliferative disorder are…
Immunohistochemistry (IHC)
CD43 Methodology Immunohistochemistry (IHC) Test Description CD43 (leukosialin, sialophorin, or leukocyte sialoglycoprotein) is a cell surface glycoprotein that is expressed on all thymocytes, T-cells…
Immunohistochemistry (IHC)
CD44 Methodology Immunohistochemistry (IHC) Test Description The CD44 family of glycoproteins exists in a number of variant isoforms, including hematopoietic variant (CD44s) and epithelial cells…
Immunohistochemistry (IHC)
CD45 (LCA) Methodology Immunohistochemistry (IHC) Test Description CD45 (Leukocyte Common Antigen, LCA) is comprised of at least four isoforms (CD45RA, CD45RB, CD45RC and CD45RO) of membrane…
Flow Cytometry
CD4/CD8 Ratio for BAL Alternative Name CD4/CD8 for Bronchoalveolar Lavage Methodology Flow Cytometry Test Description Available as global test only for bronchoalveolar…
Immunohistochemistry (IHC)
CD5 Methodology Immunohistochemistry (IHC) Test Description CD5, a transmembrane protein, is found on most thymocytes and immature peripheral T-cells. It stains normal B-cells of mantle zone of spleen…
Immunohistochemistry (IHC)
CD56 Methodology Immunohistochemistry (IHC) Test Description CD56 recognizes two proteins of the neural cell adhesion molecule, the basic molecule expressed on most neuroectodermally-derived cell…
Immunohistochemistry (IHC)
CD57 Methodology Immunohistochemistry (IHC) Test Description CD57 is expressed on subpopulations of peripheral blood mononuclear cells, NK active cells and T-cells. Hematopoietic malignancies that are…
Immunohistochemistry (IHC)
CD61 Methodology Immunohistochemistry (IHC) Test Description CD61 (GPIIIa) is a glycoprotein found on megakaryocytes, platelets, and their precursors. CD61 antigen plays a role in platelet aggregation…
Immunohistochemistry (IHC)
CD68 Methodology Immunohistochemistry (IHC) Test Description CD68 is an antibody directed against lysosomes. It is important for identifying macrophages in tissue sections. It stains macrophages in a…
Immunohistochemistry (IHC)
CD7 Methodology Immunohistochemistry (IHC) Test Description CD7 is expressed on the majority of immature and mature T-lymphocytes and T-cell leukemia. It is also found on natural killer cells, and a…
Immunohistochemistry (IHC)
CD71 Methodology Immunohistochemistry (IHC) Test Description CD71 is useful in identifying erythroid precursors with no interference from mature erythrocytes and also in the determination of erythroid…
Immunohistochemistry (IHC)
CD79a Methodology Immunohistochemistry (IHC) Test Description CD79a first appears at the pre B-cell stage and persists until the plasma cell stage where it is found as an intracellular component.…
Immunohistochemistry (IHC)
CD8 Methodology Immunohistochemistry (IHC) Test Description CD8 is a T-cell marker for the detection of cytotoxic/suppressor T-cells. CD8 is also detected on NK cells, most thymocytes, a subpopulation…
Immunohistochemistry (IHC)
CD99 Methodology Immunohistochemistry (IHC) Test Description CD99 (MIC2 gene product, E2) antigen is strongly expressed by Ewing sarcoma cells, primitive peripheral neuroectodermal tumors, and…
Immunohistochemistry (IHC)
CDK4 Methodology Immunohistochemistry (IHC) Test Description Among cyclin/CDK proteins, CDK4 and cyclin D1 are the most frequently activated by somatic genetic alterations in multiple tumor types.…
FISH
CDKN2A (p16) Deletion FISH for ALL Methodology FISH Test Description Probes: CDKN2A (p16) (9p21) | Centromere 9Disease(s): Acute Lymphoblastic Leukemia (ALL) Clinical Significance…
FISH
CDKN2A (p16) Deletion for Mesothelioma or Glioma Methodology FISH Test Description Probes: CDKN2A (p16) (9p21) | Centromere 9Disease(s): Mesothelioma, Glioma Clinical Significance…